• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿换血治疗中的药代动力学考量

Pharmacokinetic considerations in exchange transfusion in neonates.

作者信息

Yakatan G J, Smith R B, Leff R D, Kay J L

出版信息

Clin Pharmacol Ther. 1978 Jul;24(1):90-4. doi: 10.1002/cpt197824190.

DOI:10.1002/cpt197824190
PMID:657724
Abstract

Neonates undergoing blood exchange often receive concomitant therapy. Questions may be raised whether dosage regimen alterations are necessary to replace drug lost as a result of the exchange procedure. Our study reports the changes in plasma concentration of kanamycin during an exchange transfusion and a pharmacokinetic analysis of the effect of the exchange on drug elimination. The relationships of the volumes of distribution, elimination rate constant, and time after dosing on the fraction of the dose eliminated in the blood exchange are developed on the basis of a one-compartment body model. Computer simulations using the equations developed were used to estimate the fraction of a dose that might be removed as a result of an exchange transfusion. As the disposition rate constant or the apparent volume of distribution increase, i.e., the clearance of the drug increases, the fraction of the dose removed by the exchange process decreases. Thus, significant amounts of drug removal may occur in an exchange transfusion for drugs with low clearance when the exchange is initiated early in the drug dosing interval. In our study, only 3% of the kanamycin dose was removed as a result of the exchange process, and dosing adjustment would not be required. This was in part due to initiation of the exchange late in the dosing interval, although the maximum calculated percentage of the dose which could have been removed under the exchange conditions employed was only 10%.

摘要

接受换血治疗的新生儿通常会同时接受其他治疗。对于是否需要调整给药方案以补充因换血过程而损失的药物,可能会存在疑问。我们的研究报告了换血输血期间卡那霉素血浆浓度的变化以及换血对药物消除影响的药代动力学分析。基于单室模型,建立了分布容积、消除速率常数和给药后时间与换血中消除剂量分数之间的关系。使用所建立的方程进行计算机模拟,以估计因换血输血可能去除的剂量分数。随着处置速率常数或表观分布容积增加,即药物清除率增加,换血过程去除的剂量分数降低。因此,对于清除率低的药物,如果在给药间隔早期开始换血,则换血输血中可能会发生大量药物清除。在我们的研究中,换血过程仅去除了3%的卡那霉素剂量,因此无需调整给药剂量。部分原因是在给药间隔后期开始换血,尽管在所采用的换血条件下计算出的可能去除的最大剂量百分比仅为10%。

相似文献

1
Pharmacokinetic considerations in exchange transfusion in neonates.新生儿换血治疗中的药代动力学考量
Clin Pharmacol Ther. 1978 Jul;24(1):90-4. doi: 10.1002/cpt197824190.
2
Effect of exchange transfusion on serum gentamicin concentrations.换血疗法对血清庆大霉素浓度的影响。
Dev Pharmacol Ther. 1981;3(4):214-21. doi: 10.1159/000457445.
3
Alterations in gentamicin pharmacokinetics during neonatal exchange transfusion.新生儿换血期间庆大霉素药代动力学的改变。
Dev Pharmacol Ther. 1982;4(3-4):205-15. doi: 10.1159/000457409.
4
Oscillations in plasma cortisol levels of newborns during exchange transfusion.新生儿换血期间血浆皮质醇水平的波动
Endokrinologie. 1980 Jun;75(3):335-40.
5
The response of leukocytes in the peripheral blood during and following exchange transfusion in the newborn.
Pediatrics. 1973 Mar;51(3):570-4.
6
[Recommendation for the indications and execution of exchange transfusion in newborn infants].[关于新生儿换血疗法的适应证及实施的建议]
Z Arztl Fortbild (Jena). 1985;79(20):891-3.
7
[Blood group incompatibility between the mother and the child, hyperbilirubinemia of the newborn infant and exchange transfusion].[母婴血型不合、新生儿高胆红素血症与换血疗法]
Iryo. 1970;24:259-62.
8
Single versus double volume exchange transfusion in jaundiced newborn infants.黄疸新生儿单倍量与双倍量换血疗法的比较
Cochrane Database Syst Rev. 2006 Oct 18(4):CD004592. doi: 10.1002/14651858.CD004592.pub2.
9
A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.儿科药物研发中的新生儿药代动力学和药效学研究综述。
Clin Pharmacol Ther. 2015 Sep;98(3):328-35. doi: 10.1002/cpt.149.
10
Multiple exchange transfusions in the treatment of a newborn with pyruvate kinase deficiency.多次换血疗法治疗丙酮酸激酶缺乏症新生儿
Clin Pediatr (Phila). 1979 Dec;18(12):756-8. doi: 10.1177/000992287901801207.

引用本文的文献

1
Pharmacokinetics of ceftriaxone during plasma exchange in polyarteritis nodosa patients.结节性多动脉炎患者血浆置换期间头孢曲松的药代动力学
Antimicrob Agents Chemother. 1994 Jul;38(7):1519-22. doi: 10.1128/AAC.38.7.1519.
2
Effect of plasma exchange on the steady-state kinetics of digoxin and digitoxin.
Clin Pharmacokinet. 1985 Nov-Dec;10(6):514-23. doi: 10.2165/00003088-198510060-00004.
3
Clinical toxicology in the neonatal intensive care unit.新生儿重症监护病房的临床毒理学
Med Toxicol. 1986 May-Jun;1(3):225-35. doi: 10.1007/BF03259839.